+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Injectable Drug Delivery Devices Market Report 2022

  • PDF Icon

    Report

  • 175 Pages
  • May 2022
  • Region: Global
  • The Business Research Company
  • ID: 5589744
Injectable Drug Delivery Devices Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global injectable drug delivery devices market.

This report focuses on the injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the injectable drug delivery devices market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the injectable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Injectable Drug Delivery Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider injectable drug delivery devices market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this
  • The injectable drug delivery devices market section of the report gives context. It compares the injectable drug delivery devices market with other segments of the injectable drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, injectable drug delivery devices indicators comparison

Scope


Markets Covered:

1) By Type: Conventional Injectable; Pre-filled Syringes; Auto-injectors; Pen-injectors
2) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
3) By End User: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users

Companies Mentioned: Becton, Dickinson and Company; Gerresheimer AG; Eli Lilly and Company,; Pfizer inc.; Teva Pharmaceutical Industries Ltd.

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA and Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Injectable Drug Delivery Devices Market Characteristics3. Injectable Drug Delivery Devices Market Trends And Strategies4. Impact Of COVID-19 On Injectable Drug Delivery Devices
5. Injectable Drug Delivery Devices Market Size And Growth
5.1. Global Injectable Drug Delivery Devices Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Injectable Drug Delivery Devices Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Injectable Drug Delivery Devices Market Segmentation
6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Conventional Injectable
  • Pre-filled Syringes
  • Auto-injectors
  • Pen-injectors
6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare Settings
  • Pharmaceutical And Biotechnological Companies
  • Research Laboratories
  • Other End Users

7. Injectable Drug Delivery Devices Market Regional And Country Analysis
7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Injectable Drug Delivery Devices Market
8.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Injectable Drug Delivery Devices Market
9.1. China Injectable Drug Delivery Devices Market Overview
9.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Injectable Drug Delivery Devices Market
10.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Injectable Drug Delivery Devices Market
11.1. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Injectable Drug Delivery Devices Market
12.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Injectable Drug Delivery Devices Market
13.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Injectable Drug Delivery Devices Market
14.1. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Injectable Drug Delivery Devices Market
15.1. Western Europe Injectable Drug Delivery Devices Market Overview
15.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Injectable Drug Delivery Devices Market
16.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Injectable Drug Delivery Devices Market
17.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Injectable Drug Delivery Devices Market
18.3. France Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Injectable Drug Delivery Devices Market
19.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
19.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Injectable Drug Delivery Devices Market
20.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Injectable Drug Delivery Devices Market
21.1. North America Injectable Drug Delivery Devices Market Overview
21.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Injectable Drug Delivery Devices Market
22.1. USA Injectable Drug Delivery Devices Market Overview
22.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Injectable Drug Delivery Devices Market
23.1. South America Injectable Drug Delivery Devices Market Overview
23.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Injectable Drug Delivery Devices Market
24.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Injectable Drug Delivery Devices Market
25.1. Middle East Injectable Drug Delivery Devices Market Overview
25.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Injectable Drug Delivery Devices Market
26.1. Africa Injectable Drug Delivery Devices Market Overview
26.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles
27.1. Injectable Drug Delivery Devices Market Competitive Landscape
27.2. Injectable Drug Delivery Devices Market Company Profiles
27.2.1. Becton, Dickinson and Company
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Gerresheimer AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Eli Lilly and Company,
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Pfizer Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Teva Pharmaceutical Industries Ltd
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market29. Injectable Drug Delivery Devices Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi.

The global injectable drug delivery devices market is expected to grow from $34.49 billion in 2021 to $38.03 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The market is expected to grow to $55.89 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%.

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. These are used for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular, and others to treat medical conditions ranging from cancer to autoimmune disorders.

The main types of injectable drug delivery devices are conventional injectable, pre-filled syringes, auto-injectors, and pen-injectors. The prefilled syringes are the packaging with the fixed needle that contains single-dose vaccines or other medications. The injectable drug delivery devices offer applications such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others that are used by various end-users such as hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

North America was the largest region in the injectable drug delivery devices market in 2021. Western Europe was the second-largest region in the injectable drug delivery devices market. The regions in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The increasing preference for self-injection devices is driving the injectable drug delivery devices market. Self-injection devices are medical devices that can be used by the patient in-home setting for self-administration of the medication. Self-injection devices include needle-free, auto, pen, and wearable injectors. These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, which is clinically proven, reliable, and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. The other companies currently involved in the self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc, and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period.

The emergence of alternative drug delivery devices to injectable drug delivery devices is negatively affecting the market. Injectable (parenteral) drug delivery is one of the widely used conventional drug delivery systems. There are many alternative (painless) drug delivery systems such as nasal, transdermal, transmucosal, vaginal, anal, and others that are evolving. The selection of a drug delivery system depends on the drug release, absorption, distribution, metabolism, and elimination profile of the therapeutic agent to achieve the highest level of safety and efficacy from the drug. Alternative drug delivery systems hold key importance in improving bioavailability, reducing toxicity, and safety elimination of drug which is administered to treat a particular disease. Growing disease-related complications, regular developments in drugs, and combinations of therapeutic agents are used to treat disease driving the need for alternative drug delivery systems. There are some recent ongoing developments in the field of alternative drug delivery systems mainly in a nanoparticles-based delivery system, intracellular delivery system, neural delivery system, and many more. Thus, the emergence of alternative drug delivery methods limits the growth of the injectable drug delivery devices market.

The companies in injectable drug delivery devices are increasingly focusing on the manufacturing of auto-injectors. The auto-injectors are fully automated, highly customized, and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during injection. These devices can adjust the speed and depth of the automatic injection. For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming for target therapies. The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches to improve the convenience and ease of administration of parenteral therapeutics.

The countries included in the injectable drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Eli Lilly and Company
  • Pfizer inc.
  • Teva Pharmaceutical Industries ltd.
  • Schott AG
  • Baxter International
  • Owen Mumford
  • Mylan N.V.
  • Sanofi
  • Antares Pharma
  • Bespak
  • Ypsomed
  • Unilife Corporation
  • Genentech Inc.
  • Alkermes Plc.

Methodology

Loading
LOADING...